HER2 Support Group Forums - View Single Post - Positive data from Aeterna Zentaris AEZS-131 preclinical study on TNBC

News · 12-11-2011, 10:02 PM

Aeterna Zentaris Inc. today announced positive preclinical data in triple-negative breast cancer (TNBC) for its highly selective Erk 1/2 inhibitor anticancer compound, AEZS-131.

More...

12-11-2011, 10:02 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 19,721	Positive data from Aeterna Zentaris AEZS-131 preclinical study on TNBC Aeterna Zentaris Inc. today announced positive preclinical data in triple-negative breast cancer (TNBC) for its highly selective Erk 1/2 inhibitor anticancer compound, AEZS-131. More...